Clinical Trials

Showing trials with last updates posted in 2026.

NCT02808858 | RECRUITING
10000 participants

Italian Network MDS Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-04
Start Date:
2013-09-30
Completion:
2016-06-30
Conditions
  • Myelodysplastic-Myeloproliferative Diseases
No Results Yet
NCT02532452 | RECRUITING | PHASE2
1000 participants

Third Party Viral Specific T-cells (VSTs)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2015-09-02
Completion:
2028-12-31
Conditions
  • Viral Infection
  • Viral Reactivation
  • Infection in an Immunocompromised Host
Interventions
  • BIOLOGICAL
No Results Yet
NCT02208375 | ACTIVE_NOT_RECRUITING | PHASE1
159 participants

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2014-11-11
Completion:
2028-06-30
Conditions
  • BRCA1 Mutation Carrier
  • BRCA2 Mutation Carrier
  • Endometrial Adenocarcinoma
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • High Grade Ovarian Serous Adenocarcinoma
  • Progesterone Receptor Negative
  • Recurrent Breast Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Uterine Corpus Carcinoma
  • Stage III Uterine Corpus Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Stage IV Uterine Corpus Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02048332 | RECRUITING | PHASE1/PHASE2
1000 participants

Donor-Derived Viral Specific T-cells (VSTs)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2014-02-05
Completion:
2027-01-31
Conditions
  • Allogeneic Stem Cell Transplant
  • Viral Infection
  • Viral Reactivation
Interventions
  • BIOLOGICAL
No Results Yet
NCT01695941 | ACTIVE_NOT_RECRUITING | PHASE1
24 participants

Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2012-08-31
Completion:
2018-05-29
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT01524549 | COMPLETED
178 participants

Blood Vessel Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-04
Start Date:
2012-03-01
Conditions
  • Cardiovascular Disease
No Results Yet
NCT01366144 | ACTIVE_NOT_RECRUITING | PHASE1
94 participants

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2011-06-20
Completion:
2017-11-10
Conditions
  • Breast Carcinoma
  • Carcinoma of Unknown Primary
  • Endometrial Carcinoma
  • Esophageal Carcinoma
  • Liver Failure
  • Lung Carcinoma
  • Malignant Head and Neck Neoplasm
  • Malignant Testicular Neoplasm
  • Melanoma
  • Metastatic Malignant Solid Neoplasm
  • Ovarian Carcinoma
  • Renal Failure
  • Unresectable Malignant Neoplasm
  • Urothelial Carcinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00017914 | RECRUITING
1200 participants

Adult and Juvenile Myositis

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-04
Start Date:
1995-06-07
Conditions
  • Dermatomyositis
  • Polymyositis
  • Inclusion Body Myositis
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page